Velsipity to treat active ulcerative colitis in adults
Drug Name: Velsipity Active Ingredient: etrasimod Indication: To treat moderately to severely active ulcerative colitis in adults Approval Date: 10/12/2023 Company: Pfizer Inc More: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-fda-and-ema-acceptance-etrasimod